Latest Breaking News On - Estonian regional hospital cancer center - Page 1 : comparemela.com

Kersti Oselin, MD, PhD, discusses a subgroup analysis from the phase 3 PEARLS/KEYNOTE-091 study of pembrolizumab in patients with early-stage non‒small-cell lung cancer following resection.

Estonia
Kersti-oselin
Estonian-regional-hospital-cancer-center
North-estonian-regional-hospital-cancer-center
Onclive-tv
Imm60
Pembrolizumab
Keytruda
Nsclc
Lung-cancer
Nct02504372